188 related articles for article (PubMed ID: 21520243)
1. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.
Yong T; Sun A; Henry MD; Meyers S; Davis JN
J Cell Biochem; 2011 Sep; 112(9):2340-51. PubMed ID: 21520243
[TBL] [Abstract][Full Text] [Related]
2. OPTHiS Identifies the Molecular Basis of the Direct Interaction between CSL and SMRT Corepressor.
Kim GS; Park HS; Lee YC
Mol Cells; 2018 Sep; 41(9):842-852. PubMed ID: 30157580
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the CSL-KyoT2 corepressor complex: a negative regulator of Notch signaling.
Collins KJ; Yuan Z; Kovall RA
Structure; 2014 Jan; 22(1):70-81. PubMed ID: 24290140
[TBL] [Abstract][Full Text] [Related]
4. Effects of Linker Length and Transient Secondary Structure Elements in the Intrinsically Disordered Notch RAM Region on Notch Signaling.
Sherry KP; Johnson SE; Hatem CL; Majumdar A; Barrick D
J Mol Biol; 2015 Nov; 427(22):3587-3597. PubMed ID: 26344835
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network.
Ohashi S; Natsuizaka M; Yashiro-Ohtani Y; Kalman RA; Nakagawa M; Wu L; Klein-Szanto AJ; Herlyn M; Diehl JA; Katz JP; Pear WS; Seykora JT; Nakagawa H
Gastroenterology; 2010 Dec; 139(6):2113-23. PubMed ID: 20801121
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis.
Hamidi H; Gustafason D; Pellegrini M; Gasson J
PLoS One; 2011; 6(5):e20022. PubMed ID: 21637838
[TBL] [Abstract][Full Text] [Related]
7. CSL-Associated Corepressor and Coactivator Complexes.
Oswald F; Kovall RA
Adv Exp Med Biol; 2018; 1066():279-295. PubMed ID: 30030832
[TBL] [Abstract][Full Text] [Related]
8. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.
Fu W; Wang K; Zhao JL; Yu HC; Li SZ; Lin Y; Liang L; Huang SY; Liang YM; Han H; Qin HY
BMC Cancer; 2014 Jun; 14():463. PubMed ID: 24952875
[TBL] [Abstract][Full Text] [Related]
9. Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage.
Deregowski V; Gazzerro E; Priest L; Rydziel S; Canalis E
J Bone Miner Res; 2006 Aug; 21(8):1317-26. PubMed ID: 16869730
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of RBP-J-interacting and tubulin-associated (RITA) reveals regions critical for repression of Notch target genes.
Tabaja N; Yuan Z; Oswald F; Kovall RA
J Biol Chem; 2017 Jun; 292(25):10549-10563. PubMed ID: 28487372
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CSL (CBF-1, Su(H), Lag-1) mutants reveals differences in signaling mediated by Notch1 and Notch2.
Yuan Z; Friedmann DR; VanderWielen BD; Collins KJ; Kovall RA
J Biol Chem; 2012 Oct; 287(42):34904-34916. PubMed ID: 22915591
[TBL] [Abstract][Full Text] [Related]
12. Notch-independent functions of CSL.
Johnson JE; Macdonald RJ
Curr Top Dev Biol; 2011; 97():55-74. PubMed ID: 22074602
[TBL] [Abstract][Full Text] [Related]
13. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
14. Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL.
Del Bianco C; Vedenko A; Choi SH; Berger MF; Shokri L; Bulyk ML; Blacklow SC
PLoS One; 2010 Nov; 5(11):e15034. PubMed ID: 21124806
[TBL] [Abstract][Full Text] [Related]
15. The effects of conformational heterogeneity on the binding of the Notch intracellular domain to effector proteins: a case of biologically tuned disorder.
Bertagna A; Toptygin D; Brand L; Barrick D
Biochem Soc Trans; 2008 Apr; 36(Pt 2):157-66. PubMed ID: 18363556
[TBL] [Abstract][Full Text] [Related]
16. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.
Caolo V; van den Akker NM; Verbruggen S; Donners MM; Swennen G; Schulten H; Waltenberger J; Post MJ; Molin DG
J Biol Chem; 2010 Dec; 285(52):40681-9. PubMed ID: 20959466
[TBL] [Abstract][Full Text] [Related]
17. RAM-induced allostery facilitates assembly of a notch pathway active transcription complex.
Friedmann DR; Wilson JJ; Kovall RA
J Biol Chem; 2008 May; 283(21):14781-91. PubMed ID: 18381292
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological disruption of the Notch transcription factor complex.
Lehal R; Zaric J; Vigolo M; Urech C; Frismantas V; Zangger N; Cao L; Berger A; Chicote I; Loubéry S; Choi SH; Koch U; Blacklow SC; Palmer HG; Bornhauser B; González-Gaitán M; Arsenijevic Y; Zoete V; Aster JC; Bourquin JP; Radtke F
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16292-16301. PubMed ID: 32601208
[TBL] [Abstract][Full Text] [Related]
19. Dissecting and circumventing the requirement for RAM in CSL-dependent Notch signaling.
Johnson SE; Barrick D
PLoS One; 2012; 7(8):e39093. PubMed ID: 22876274
[TBL] [Abstract][Full Text] [Related]
20. Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.
Al Labban D; Jo SH; Ostano P; Saglietti C; Bongiovanni M; Panizzon R; Dotto GP
J Clin Invest; 2018 Jun; 128(6):2581-2599. PubMed ID: 29757189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
